Role of secondary cytoreductive surgery in ovarian cancer relapse: who will benefit? A systematic analysis of 240 consecutive patients.
Related Research units
Abstract
In contrast to primary ovarian cancer, the value of surgery in relapsed-OC (ROC) remains unclear. We evaluated surgical and clinical outcome of secondary cytoreduction in ROC.
Bibliographical data
| Original language | German |
|---|---|
| Article number | 6 |
| ISSN | 0022-4790 |
| Publication status | Published - 2010 |
| pubmed | 20734422 |
|---|
